Nu Skin Enterprises, Inc. (NUS) Stock Forecast
NUS analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $12.77 average of analyst targets
- Upside to target
- +148.4% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.21
- 52-week range
- $4.53 – $11.54
NUS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NUS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.21 | $0.21 | $0.21 | $0.34 | −38.2% | 1 |
| Current fiscal year (2026) | $0.82 | $0.82 | $0.82 | $1.27 | −35.4% | 1 |
| Next fiscal year (2027) | $1.16 | $1.16 | $1.16 | $0.82 | +41.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NUS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $328.7M | $328.7M | $328.7M | −9.8% | 1 |
| Current fiscal year (2026) | $1.32B | $1.32B | $1.32B | −11.3% | 1 |
| Next fiscal year (2027) | $1.47B | $1.47B | $1.47B | +11.9% | 1 |
NUS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NUS revenue: reported and forecast
NUS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.32 | $0.32 | $0.32 | $0.32 | $0.21 | −34.4% | 0 up · 1 down |
| Current fiscal year (2026) | $1.00 | $1.00 | $1.00 | $1.00 | $0.82 | −18.0% | 0 up · 1 down |
| Next fiscal year (2027) | $1.32 | $1.32 | $1.32 | $1.32 | $1.16 | −12.1% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NUS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NUS beat in 8 of 12.
What analysts expect from NUS
The average price target is $12.77, 148.4% above the latest close of $5.14. Analysts expect earnings of $0.82 per share for 2026, −35.4% from a year earlier. For 2027 the average estimate is $1.16 per share on revenue of $1.5 billion. Nu Skin Enterprises beat the EPS estimate in 8 of the last 12 quarters.
Related: NUS income statement, NUS key metrics, NUS chart. See the NUS stock overview for the latest quote and news.
NUS forecast FAQ
What is Nu Skin Enterprises's price target?
The average analyst price target for Nu Skin Enterprises is $12.77, 148.4% above the latest close of $5.14.
What is Nu Skin Enterprises's EPS forecast?
Analysts forecast $0.82 per share for 2026 (range $0.82 to $0.82); for 2027 the estimate is $1.16.
What is Nu Skin Enterprises's revenue forecast?
The average revenue estimate for 2026 is $1.3 billion, growth of −11.3%; for 2027 it is $1.5 billion.
When does Nu Skin Enterprises report earnings?
Nu Skin Enterprises is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.21.
Does Nu Skin Enterprises usually beat earnings estimates?
Nu Skin Enterprises reported EPS at or above the analyst estimate in 8 of the last 12 quarters.